Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer
- Zhu Wang1,2,*,
- Dinglan Wu1,3,*,
- Chi-Fai Ng4,
- Jeremy Yuen-Chun Teoh4,
- Shan Yu1,
- Yuliang Wang1⇑ and
- Franky L Chan1⇑
- 1School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China
- 2Department of Urology, People’s Hospital of Longhua, Shenzhen, China
- 3The Clinical Innovation & Research Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- 4Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China
- Correspondence should be addressed to Y Wang or F L Chan: yuliang.wang816{at}gmail.com or franky-chan{at}cuhk.edu.hk
Abstract
Nuclear receptors (NRs), which belong to a superfamily of transcription factors and consist of a total of 48 members in humans, govern the expression of genes involved in a board range of developmental, reproductive, metabolic and immunological programs. Given the significant importance of androgen receptor and a few known NRs in the progression of prostate cancer, we surveyed the expression profiles of the entire NR superfamily in three-dimensional cultured prostatospheroids derived from different prostate cancer cell lines and a tumor xenograft model of castration-resistant prostate cancer VCaP-CRPC by quantitative real-time RT-PCR. Our results revealed that prostatospheroids and castration-relapse VCaP-CRPC xenografts, both contained enriched populations of prostate cancer stem/progenitor-like cells (PCSCs), displayed distinct expression patterns of NRs. Intriguingly, most of these differentially expressed NRs were orphan NRs and showed upregulation. Pairwise analysis identified five orphan NRs (including RORβ, TLX, COUP-TFII, NURR1 and LRH-1) that showed common upregulation in both mRNA and protein levels in the prostatospheroids and castration-relapse VCaP-CRPC xenografts, and overexpression of these orphan NRs could increase cancer stem cell marker expressions and enhance spheroid formation capacity in prostate cancer cells, suggesting that these orphan NRs might perform positive roles in the growth regulation of PCSCs and castration-resistant prostate cancer. Together, our NR expression dataset not only revealed the distinct physiologic status and regulatory roles governed by the networks of specific NRs but also some of these identified orphan NRs could be the potential therapeutic targets for PCSCs or castration-resistant prostate cancer.
- nuclear receptors
- orphan nuclear receptors
- prostate cancer
- castration resistance
- prostate cancer stem-like cells
- Received 12 October 2017
- Accepted 17 October 2017
- Made available online as an Accepted Preprint 17 October 2017
- © 2018 Society for Endocrinology